332 related articles for article (PubMed ID: 18470951)
21. EsiRNAs inhibit Hepatitis B virus replication in mice model more efficiently than synthesized siRNAs.
Xuan B; Qian Z; Hong J; Huang W
Virus Res; 2006 Jun; 118(1-2):150-5. PubMed ID: 16423421
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines.
Kayhan H; Karatayli E; Turkyilmaz AR; Sahin F; Yurdaydin C; Bozdayi AM
Arch Virol; 2007; 152(5):871-9. PubMed ID: 17245534
[TBL] [Abstract][Full Text] [Related]
23. Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation.
Bagis H; Arat S; Mercan HO; Aktoprakligil D; Caner M; Turanli ET; Baysal K; Turgut G; Sekmen S; Cirakoglu B
J Exp Zool A Comp Exp Biol; 2006 May; 305(5):420-7. PubMed ID: 16489557
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of hepatitis B virus in mice by RNA interference.
McCaffrey AP; Nakai H; Pandey K; Huang Z; Salazar FH; Xu H; Wieland SF; Marion PL; Kay MA
Nat Biotechnol; 2003 Jun; 21(6):639-44. PubMed ID: 12740585
[TBL] [Abstract][Full Text] [Related]
25. B7-DC-silenced dendritic cells induce stronger anti-HBV immunity in transgenic mice.
Fan Y; Jiang WZ; Wen JJ; Hao WL; Du JN; Liu X; Qian M
Arch Virol; 2009; 154(11):1813-21. PubMed ID: 19838621
[TBL] [Abstract][Full Text] [Related]
26. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication.
Morrissey DV; Blanchard K; Shaw L; Jensen K; Lockridge JA; Dickinson B; McSwiggen JA; Vargeese C; Bowman K; Shaffer CS; Polisky BA; Zinnen S
Hepatology; 2005 Jun; 41(6):1349-56. PubMed ID: 15880588
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic short hairpin RNA expression in the liver: viral targets and vectors.
Grimm D; Kay MA
Gene Ther; 2006 Mar; 13(6):563-75. PubMed ID: 16453009
[TBL] [Abstract][Full Text] [Related]
28. An adenovirus-delivered peptide aptamer C1-1 targeting the core protein of hepatitis B virus inhibits viral DNA replication and production in vitro and in vivo.
Zhang W; Ke W; Wu SS; Gan L; Zhou R; Sun CY; Long QS; Jiang W; Xin HB
Peptides; 2009 Oct; 30(10):1816-21. PubMed ID: 19619601
[TBL] [Abstract][Full Text] [Related]
29. [Antiviral effects of dual-target antisense rna: an experimental study with hepatitis B virus transgenic mice].
Zhao W; Chen H; Peng ZY; Li WG; Xi HL; Xu XY
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3486-90. PubMed ID: 16686065
[TBL] [Abstract][Full Text] [Related]
30. Adenoviral-vector mediated transfer of HBV-targeted ribonuclease can inhibit HBV replication in vivo.
Zhao Y; Li Y; Liu J; Liu Z; Huang Y; Lei J; Li S; Xue C
Biochem Biophys Res Commun; 2008 Jul; 371(3):541-5. PubMed ID: 18455508
[TBL] [Abstract][Full Text] [Related]
31. Viral covalently closed circular DNA in a non-transgenic mouse model for chronic hepatitis B virus replication.
Takehara T; Suzuki T; Ohkawa K; Hosui A; Jinushi M; Miyagi T; Tatsumi T; Kanazawa Y; Hayashi N
J Hepatol; 2006 Feb; 44(2):267-74. PubMed ID: 16226822
[TBL] [Abstract][Full Text] [Related]
32. [Construction of plasmid stably expressing shRNA and inhibition of HBV replication and expression].
Zhang HB; Wu J; Zheng WL; Ma WL; Xian J; Xie WY; Li W; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):898-900. PubMed ID: 17908493
[TBL] [Abstract][Full Text] [Related]
33. Intracellular application of hairpin ribozyme genes against hepatitis B virus.
Welch PJ; Tritz R; Yei S; Barber J; Yu M
Gene Ther; 1997 Jul; 4(7):736-43. PubMed ID: 9282175
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profile of transgenic mouse kidney reveals pathogenesis of hepatitis B virus associated nephropathy.
Ren J; Wang L; Chen Z; Ma ZM; Zhu HG; Yang DL; Li XY; Wang BI; Fei J; Wang ZG; Wen YM
J Med Virol; 2006 May; 78(5):551-60. PubMed ID: 16555286
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
Nash KL; Alexander GJ; Lever AM
J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
37. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
38. Exploiting the RNA interference pathway to counter hepatitis B virus replication.
Arbuthnot P; Carmona S; Ely A
Liver Int; 2005 Feb; 25(1):9-15. PubMed ID: 15698393
[TBL] [Abstract][Full Text] [Related]
39. RNA interference against hepatitis B virus with endoribonuclease-prepared siRNA despite of the target sequence variations.
Tan C; Xuan B; Hong J; Dai Z; Hao R; Li Z; Huang W
Virus Res; 2007 Jun; 126(1-2):172-8. PubMed ID: 17399837
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection.
Untergasser A; Zedler U; Langenkamp A; Hösel M; Quasdorff M; Esser K; Dienes HP; Tappertzhofen B; Kolanus W; Protzer U
Hepatology; 2006 Mar; 43(3):539-47. PubMed ID: 16496321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
